News & Updates

Show Multimedia Only

PROTEUS sets new course for prostate cancer

11 Jun 2026 by

In the final analysis of the phase III PROTEUS trial, perioperative apalutamide + androgen deprivation therapy (APA+ADT) improves the curative success of radical prostatectomy (RP) in men with high-risk localized or locally advanced prostate cancer (HR LPC/LAPC).

PROTEUS sets new course for prostate cancer

11 Jun 2026

Azithromycin of little benefit in preschool-age children with acute wheezing

11 Jun 2026

Azithromycin appears to only be as good as placebo in the treatment of preschool-age children presenting to the emergency department (ED) with moderate-to-severe acute wheezing, according to a study.

Azithromycin of little benefit in preschool-age children with acute wheezing

11 Jun 2026

Real-world data confirm effectiveness of dupilumab in eosinophilic esophagitis

10 Jun 2026

Dupilumab has been shown to reduce symptomatic, endoscopic, and histological eosinophilic esophagitis (EoE) markers for patients treated in routine practice, as shown in the retrospective DUPEOETALY study.

Real-world data confirm effectiveness of dupilumab in eosinophilic esophagitis

10 Jun 2026

One in five patients with chronic HBV infection achieves functional cure with bepirovirsen

10 Jun 2026 by

The novel antisense oligonucleotide bepirovirsen has induced functional cure in one-fifth of patients with chronic hepatitis B virus (HBV) infection in the phase 3 B-Well 1 and B-Well 2 trials.

One in five patients with chronic HBV infection achieves functional cure with bepirovirsen

10 Jun 2026

Rheumatology patients must undergo screening for anxiety, depression, FM: study

10 Jun 2026

A significant proportion of rheumatology patients have been diagnosed with anxiety, depression, or fibromyalgia (FM), reveals a study, noting the importance of including screening for clinical decisions at all routine encounters.

Rheumatology patients must undergo screening for anxiety, depression, FM: study

10 Jun 2026

Heavy alcohol consumption raises CRC risk

10 Jun 2026 by

Individuals with high alcohol consumption are at increased risk of colorectal cancer (CRC), reports a study, which shows that alcohol intake may trigger colorectal carcinogenesis through mechanisms operating across major molecular pathways for CRC.

Heavy alcohol consumption raises CRC risk

10 Jun 2026

$TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients$

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

10 Jun 2026

Patients with radiographic axial spondyloarthritis (r-axSpA) who have been exposed to tumour necrosis factor inhibitor (TNFi) and interleukin (IL)-17 inhibitor (IL-17i) appear to have a lower risk of osteoporosis, but not hip fracture, than biologic disease-modifying antirheumatic drug (bDMARD)-naïve individuals, a recent study has shown.

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

10 Jun 2026

LNF-based regimens may alter trajectory of CHD treatment

10 Jun 2026 by

Individuals with chronic hepatitis D (CHD) may benefit from lonafarnib boosted with ritonavir (LNF/RTV) alone or in combination with peg-interferon-alfa (PEG), findings from the phase III D-LIVR trial have shown.

LNF-based regimens may alter trajectory of CHD treatment

10 Jun 2026

$Lutikizumab shows promise in refractory hidradenitis suppurativa$

Lutikizumab shows promise in refractory hidradenitis suppurativa

10 Jun 2026

Treatment with lutikizumab appears to improve outcomes in patients with moderate-to-severe hidradenitis suppurativa (HS) who have not responded to anti-TNF therapy, according to a phase II trial.

Lutikizumab shows promise in refractory hidradenitis suppurativa

10 Jun 2026

Adverse reproductive factors plus unhealthy lifestyle tied to higher risk of cognitive decline

09 Jun 2026

In Chinese postmenopausal women, adverse reproductive factors combined with unhealthy lifestyle behaviours appear to be associated with increased likelihood of cognitive decline, as reported in a study.

Adverse reproductive factors plus unhealthy lifestyle tied to higher risk of cognitive decline

09 Jun 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

PROTEUS sets new course for prostate cancer

PROTEUS sets new course for prostate cancer

Azithromycin of little benefit in preschool-age children with acute wheezing

Azithromycin of little benefit in preschool-age children with acute wheezing

Real-world data confirm effectiveness of dupilumab in eosinophilic esophagitis

Real-world data confirm effectiveness of dupilumab in eosinophilic esophagitis

One in five patients with chronic HBV infection achieves functional cure with bepirovirsen

One in five patients with chronic HBV infection achieves functional cure with bepirovirsen

Rheumatology patients must undergo screening for anxiety, depression, FM: study

Rheumatology patients must undergo screening for anxiety, depression, FM: study

Heavy alcohol consumption raises CRC risk

Heavy alcohol consumption raises CRC risk

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

LNF-based regimens may alter trajectory of CHD treatment

LNF-based regimens may alter trajectory of CHD treatment

Lutikizumab shows promise in refractory hidradenitis suppurativa

Lutikizumab shows promise in refractory hidradenitis suppurativa

Adverse reproductive factors plus unhealthy lifestyle tied to higher risk of cognitive decline

Adverse reproductive factors plus unhealthy lifestyle tied to higher risk of cognitive decline